Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-046135
Filing Date
2025-12-19
Accepted
2025-12-19 09:26:26
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20061157_defa14a.htm DEFA14A 956380
2 ef20061157_ex99-7slide1.jpg GRAPHIC 221098
3 ef20061157_ex99-7slide2.jpg GRAPHIC 365257
4 image0.jpg GRAPHIC 8820
5 image00001.jpg GRAPHIC 48891
6 image00002.jpg GRAPHIC 3305
7 image00004.jpg GRAPHIC 4673
  Complete submission text file 0001140361-25-046135.txt   1856305
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 251585527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)